Operating Income (Loss) in USD of CVS HEALTH Corp from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
CVS HEALTH Corp quarterly/annual Operating Income (Loss) history and change rate from Q1 2010 to Q3 2025.
  • CVS HEALTH Corp Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$3.21B, a 485% decline year-over-year.
  • CVS HEALTH Corp Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $4.92B, a 48.4% decline year-over-year.
  • CVS HEALTH Corp annual Operating Income (Loss) for 2024 was $8.52B, a 38% decline from 2023.
  • CVS HEALTH Corp annual Operating Income (Loss) for 2023 was $13.7B, a 72.8% increase from 2022.
  • CVS HEALTH Corp annual Operating Income (Loss) for 2022 was $7.95B, a 40.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

CVS HEALTH Corp Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $4.92B -$3.21B -$4.04B -485% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025
Q2 2025 $8.96B $2.38B -$664M -21.8% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025
Q1 2025 $9.62B $3.37B +$1.1B +48.6% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $8.52B $2.37B -$1.01B -29.8% 01 Oct 2024 31 Dec 2024 10-K 12 Feb 2025
Q3 2024 $9.52B $832M -$2.86B -77.5% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025
Q2 2024 $12.4B $3.05B -$189M -5.84% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025
Q1 2024 $12.6B $2.27B -$1.18B -34.1% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 $13.7B $3.37B -$286M -7.82% 01 Oct 2023 31 Dec 2023 10-K 12 Feb 2025
Q3 2023 $14B $3.69B +$7.61B 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 $6.42B $3.23B -$1.44B -30.7% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 $7.86B $3.45B -$99M -2.79% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024
Q4 2022 $7.95B $3.66B +$1.31B +56% 01 Oct 2022 31 Dec 2022 10-K 12 Feb 2025
Q3 2022 $6.64B -$3.92B -$6.98B -228% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023
Q2 2022 $13.6B $4.67B +$343M +7.93% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023
Q1 2022 $13.3B $3.55B -$32M -0.9% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023
Q4 2021 $13.3B $2.35B -$178M -7.05% 01 Oct 2021 31 Dec 2021 10-K 07 Feb 2024
Q3 2021 $13.5B $3.06B -$188M -5.79% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $13.7B $4.33B -$354M -7.56% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 $14B $3.58B +$119M +3.44% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 $13.9B $2.52B -$513M -16.9% 01 Oct 2020 31 Dec 2020 8-K 25 May 2023
Q3 2020 $14.4B $3.25B +$321M +11% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2020 $14.1B $4.68B +$1.35B +40.5% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 $12.8B $3.46B +$768M +28.6% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021
Q4 2019 $12B $3.04B +$2.21B +269% 01 Oct 2019 31 Dec 2019 10-K 18 Feb 2020
Q3 2019 $9.77B $2.93B +$354M +13.8% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 $9.42B $3.33B +$4.71B 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020
Q1 2019 $4.72B $2.69B +$694M +34.8% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020
Q4 2018 $4.02B $824M -$2.29B -73.5% 01 Oct 2018 31 Dec 2018 10-K 18 Feb 2020
Q3 2018 $6.31B $2.57B +$70M +2.8% 01 Jul 2018 30 Sep 2018 10-K 18 Feb 2020
Q2 2018 $6.24B -$1.37B -$3.49B -165% 01 Apr 2018 30 Jun 2018 10-K 18 Feb 2020
Q1 2018 $9.74B $2B +$197M +11% 01 Jan 2018 31 Mar 2018 10-K 18 Feb 2020
Q4 2017 $9.54B $3.11B +$114M +3.8% 01 Oct 2017 31 Dec 2017 8-K 08 Aug 2019
Q3 2017 $9.42B $2.5B -$320M -11.3% 01 Jul 2017 30 Sep 2017 8-K 08 Aug 2019
Q2 2017 $9.74B $2.12B -$236M -10% 01 Apr 2017 30 Jun 2017 8-K 08 Aug 2019
Q1 2017 $9.98B $1.8B -$386M -17.7% 01 Jan 2017 31 Mar 2017 8-K 08 Aug 2019
Q4 2016 $10.4B $3B +$271M +9.93% 01 Oct 2016 31 Dec 2016 10-K 14 Feb 2018
Q3 2016 $10.1B $2.82B +$493M +21.2% 01 Jul 2016 30 Sep 2016 10-K 14 Feb 2018
Q2 2016 $9.6B $2.36B +$95M +4.2% 01 Apr 2016 30 Jun 2016 10-K 14 Feb 2018
Q1 2016 $9.51B $2.19B +$53M +2.49% 01 Jan 2016 31 Mar 2016 10-K 14 Feb 2018
Q4 2015 $9.45B $2.73B +$408M +17.6% 01 Oct 2015 31 Dec 2015 10-K 09 Feb 2017
Q3 2015 $9.05B $2.33B +$85M +3.79% 01 Jul 2015 30 Sep 2015 10-K 09 Feb 2017
Q2 2015 $8.96B $2.26B +$54M +2.45% 01 Apr 2015 30 Jun 2015 10-K 09 Feb 2017
Q1 2015 $8.91B $2.13B +$108M +5.34% 01 Jan 2015 31 Mar 2015 10-K 09 Feb 2017
Q4 2014 $8.8B $2.32B +$104M +4.69% 01 Oct 2014 31 Dec 2014 10-K 09 Feb 2016
Q3 2014 $8.7B $2.25B +$92M +4.27% 01 Jul 2014 30 Sep 2014 10-K 09 Feb 2016
Q2 2014 $8.6B $2.21B +$236M +12% 01 Apr 2014 30 Jun 2014 10-K 09 Feb 2016
Q1 2014 $8.37B $2.02B +$330M +19.5% 01 Jan 2014 31 Mar 2014 10-K 09 Feb 2016
Q4 2013 $8.04B $2.22B -$82M -3.57% 01 Oct 2013 31 Dec 2013 10-K 10 Feb 2015
Q3 2013 $8.12B $2.15B +$342M +18.9% 01 Jul 2013 30 Sep 2013 10-K 10 Feb 2015
Q2 2013 $7.78B $1.97B +$270M +15.9% 01 Apr 2013 30 Jun 2013 10-K 10 Feb 2015
Q1 2013 $7.51B $1.69B +$297M +21.3% 01 Jan 2013 31 Mar 2013 10-K 10 Feb 2015
Q4 2012 $7.21B $2.3B +$342M +17.5% 01 Oct 2012 31 Dec 2012 10-K 11 Feb 2014
Q3 2012 $6.87B $1.81B +$228M +14.4% 01 Jul 2012 30 Sep 2012 10-K 11 Feb 2014
Q2 2012 $6.64B $1.7B +$218M +14.7% 01 Apr 2012 30 Jun 2012 10-K 11 Feb 2014
Q1 2012 $6.42B $1.4B +$92M +7.05% 01 Jan 2012 31 Mar 2012 10-K 11 Feb 2014
Q4 2011 $6.33B $1.96B +$196M +11.1% 01 Oct 2011 31 Dec 2011 10-K 15 Feb 2013
Q3 2011 $6.13B $1.58B +$106M +7.17% 01 Jul 2011 30 Sep 2011 10-K 15 Feb 2013
Q2 2011 $6.03B $1.48B -$10M -0.67% 01 Apr 2011 30 Jun 2011 10-K 15 Feb 2013
Q1 2011 $6.04B $1.31B -$99M -7.05% 01 Jan 2011 31 Mar 2011 10-K 15 Feb 2013
Q4 2010 $6.14B $1.76B 01 Oct 2010 31 Dec 2010 10-K 17 Feb 2012
Q3 2010 $1.48B 01 Jul 2010 30 Sep 2010 10-K 17 Feb 2012
Q2 2010 $1.49B 01 Apr 2010 30 Jun 2010 10-K 17 Feb 2012
Q1 2010 $1.4B 01 Jan 2010 31 Mar 2010 10-K 17 Feb 2012

CVS HEALTH Corp Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $8.52B -$5.23B -38% 01 Jan 2024 31 Dec 2024 10-K 12 Feb 2025
2023 $13.7B +$5.79B +72.8% 01 Jan 2023 31 Dec 2023 10-K 12 Feb 2025
2022 $7.95B -$5.36B -40.2% 01 Jan 2022 31 Dec 2022 10-K 12 Feb 2025
2021 $13.3B -$601M -4.32% 01 Jan 2021 31 Dec 2021 10-K 07 Feb 2024
2020 $13.9B +$1.92B +16.1% 01 Jan 2020 31 Dec 2020 8-K 25 May 2023
2019 $12B +$7.97B +198% 01 Jan 2019 31 Dec 2019 10-K 09 Feb 2022
2018 $4.02B -$5.52B -57.8% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021
2017 $9.54B -$848M -8.17% 01 Jan 2017 31 Dec 2017 10-K 18 Feb 2020
2016 $10.4B +$911M +9.62% 01 Jan 2016 31 Dec 2016 8-K 08 Aug 2019
2015 $9.48B +$676M +7.68% 01 Jan 2015 31 Dec 2015 10-K 14 Feb 2018
2014 $8.8B +$762M +9.48% 01 Jan 2014 31 Dec 2014 10-K 09 Feb 2017
2013 $8.04B +$827M +11.5% 01 Jan 2013 31 Dec 2013 10-K 09 Feb 2016
2012 $7.21B +$879M +13.9% 01 Jan 2012 31 Dec 2012 10-K 10 Feb 2015
2011 $6.33B +$194M +3.16% 01 Jan 2011 31 Dec 2011 10-K 11 Feb 2014
2010 $6.14B 01 Jan 2010 31 Dec 2010 10-K 15 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.